Abstract
In 2016, the Psychoactive Substances Act came into force to address increasing concerns about the use of new psychoactive substances (NPS), also known as designer drugs or ‘legal highs’. But how big is the problem, and what impact is the new Act likely to have?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have